1. Volume 371, Issue 9628, Pages 1927-1935 (June 2008)
Can metabolic syndrome usefully predict cardiovascular disease and diabetes? Outcome data from two prospective studies 
Prof Naveed Sattar, FRCPath, Alex McConnachie, PhD, Prof A Gerald Shaper, FRCP, Gerard J Blauw, MD, Prof Brendan M Buckley, FRCPI, Anton J de Craen, PhD, Prof Ian Ford, PhD, Nita G Forouhi, FFPH, Dilys J Freeman, PhD, Prof J Wouter Jukema, MD, Lucy Lennon, MSc, Prof Peter W Macfarlane, DSc, Prof Michael B Murphy, MD, Prof Chris J Packard, DSc, Prof David J Stott, MD, Prof Rudi G Westendorp, MD, Prof Peter H Whincup, FRCP, Prof James Shepherd, MD, S Goya Wannamethee, PhD 
The Lancet 
Volume 371, Issue 9628, Pages (June 2008)
DOI: /S (08)
Copyright © 2008 Elsevier Ltd Terms and Conditions

2. Figure
Cumulative event rates by presence or absence of metabolic syndrome and every metabolic factor at baseline, in participants without baseline vascular disease in PROSPER
(A) Events of cardiovascular disease. (B) Events of incident diabetes. Criteria were: BMI ≥30 kg/m2; triglyceride ≥1·69 mmol/L; HDL cholesterol <1·04 mmol/L (men) or <1·29 mmol/L (women); fasting glucose ≥6·1 mmol/L; and systolic blood pressure ≥130 mm Hg, diastolic blood pressure ≥85 mm Hg, or treated hypertensive. CVD=cardiovascular disease. BMI=body-mass index.
The Lancet  , DOI: ( /S (08) )
Copyright © 2008 Elsevier Ltd Terms and Conditions